Results 11 to 20 of about 707 (169)

Equine allergic skin diseases: Clinical consensus guidelines of the World Association for Veterinary Dermatology

Veterinary Dermatology, Volume 34, Issue 3, Page 175-208, June 2023., 2023
Abstract Background Allergic skin diseases are common in horses worldwide. The most common causes are insect bites and environmental allergens. Objectives To review the current literature and provide consensus on pathogenesis, diagnosis, treatment and prevention. Materials and Methods The authors reviewed the literature up to November 2022.
R. Marsella, S. White, V. A. Fadok, D. Wilson, R. Mueller, C. Outerbridge, W. Rosenkrantz   +6 more
wiley   +1 more source

Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases

Veterinary Dermatology, Volume 33, Issue 4, Page 321-e75, August 2022., 2022
Background –Canine atopic dermatitis (cAD) is an allergic skin disease affecting approximately 10% of dogs. Allergen immunotherapy (AIT) is currently the only treatment option able to induce tolerance to the causative allergens. Objective – To retrospectively establish the efficacy of AIT in atopic dogs.
Evelien E. M. Fennis, Catharina M. M. van Damme, Yvette M. Schlotter, Jacqueline D. Sinke, Mieke H. G. Leistra, Richard T. Bartels, Femke Broere   +6 more
wiley   +1 more source

An international seroprevalence survey of the IgE sensitisation to the Dermatophagoides farinae house dust mite and two of its major allergens (Der f 2, Zen 1) in atopic dogs

Veterinary Dermatology, Volume 33, Issue 2, Page 117-e34, April 2022., 2022
Background – Dogs with atopic dermatitis are often immunoglobulin (Ig)E‐sensitised to Dermatophagoides farinae (Df) house dust mites, yet limited data exist on the sensitisation rates to the individual Df allergens, Der f 2 and Zen 1. Objectives – To determine the IgE sensitisation rates to Df, Der f 2 and Zen 1 in atopic dogs from geographically ...
Claude Favrot, Thierry Olivry, Toshiro Iwasaki   +2 more
wiley   +1 more source

Immunopathogenesis and immunotherapy of Culicoides hypersensitivity in horses: an update

Veterinary Dermatology, Volume 32, Issue 6, Page 579-e156, December 2021., 2021
Culicoides hypersensitivity (CH) is a strongly pruritic dermatitis of horses, characterised histologically by mixed perivascular to diffuse cellular infiltrates of mononuclear cells and eosinophils, and caused by helper T cell (Th)2, immunoglobulin (Ig)E‐mediated reactions to antigens present in the saliva of biting Culicoides midges.
Eliane Marti, Ella N. Novotny, Iva Cvitas, Anja Ziegler, A. Douglas Wilson, Sigurbjörg Torsteinsdottir, Antonia Fettelschoss‐Gabriel, Sigridur Jonsdottir   +7 more
wiley   +1 more source

Reproducibility of serum testing for environmental allergen‐specific IgE in dogs in Europe

Veterinary Dermatology, Volume 32, Issue 3, Page 251-e67, June 2021., 2021
Background – Serum testing for allergen‐specific immunoglobulin (Ig)E is commonly employed to identify allergens used for allergen‐specific immunotherapy in dogs, yet the reliability of results has been a matter of debate. Objective – The aim of this study was to evaluate the reproducibility of serum tests for environmental allergen‐specific IgE in ...
Katja N. Baumann, Natalie K.Y. Gedon, Teresa M.S.A. Boehm, Laura Udraite‐Vovk, Ralf S. Mueller   +4 more
wiley   +1 more source

Detección de anticuerpos del SARS–CoV–2 en perros en contacto con humanos positivos COVID–19

Revista Científica, 2022
El objetivo del presente estudio fue detectar la presencia de anticuerpos IgG e IgM para el SARS-CoV-2 en mascotas que tuvieron contacto con humanos positivos a COVID–19 de la parroquia de Alangasí, perteneciente a la ciudad de Quito, Ecuador, durante ...
Roberto Danilo Chiliquinga-Quinchiguano, Nathalie Campos-Murillo, Edy Castillo-Hidalgo   +2 more
doaj   +1 more source

Immunopathogenesis of the feline atopic syndrome

Veterinary Dermatology, Volume 32, Issue 1, Page 13-e4, February 2021., 2021
Résumé Contexte Les maladies félines supposées d’origine allergique avec des phénotypes cliniques semblables, peuvent avoir de nombreuses pathogénies différentes sous jacentes. Le phénotype clinque, l’étiologie précise et l’immunopathogénie sous jacente doivent tous être considérés si des avancées veulent être faites dans ces domaines négligés de la ...
Richard Halliwell, Frane Banovic, Ralf S. Mueller, Thierry Olivry   +3 more
wiley   +1 more source

Evaluación de la seroconversión de anticuerpos contra SARS-COV-2

Magna Scientia UCEVA, 2022
Conocer la respuesta inmunitaria dada por la presencia de anticuerpos detectables y demostrar la presencia de anticuerpos específicos generada por la seroconversión, son parámetros útiles en el momento en el cual, se llevó a cabo la investigación, para ...
Diego Fernando López Muñoz, Luz Adriana Suárez Jaramillo, Leonel Gulloso Pedrozo, Sandra Milena Gómez Guerrero, Angélica Sánchez Moncayo, Beatriz Giraldo Ospina   +5 more
doaj   +1 more source

Minimización de costos: inmunoglobulina IV vs. plasmaféresis en síndrome de Guillain Barré

Acta Neurológica Colombiana, 2023
Introducción: el síndrome de Guillain Barré es considerada una de las principales causas de parálisis neuromuscular aguda. Actualmente existen dos alternativas igual de efectivas clínicamente en el tratamiento de esta enfermedad: la inmunoglobulina ...
Fabio Enrique Suárez, Gloria Isabel Ortiz, Juan Pablo Mogollón, Liliana Clavijo, Paola Andrea Ortíz , Jesús Hernán Rodríguez, Jorge Mutis   +6 more
doaj   +2 more sources

Aplicaciones terapéuticas del eculizumab

Universidad y Salud, 2022
Introducción: El eculizumab es un anticuerpo monoclonal de tipo IgG diseñado para el tratamiento de la hemoglobinuria paroxística nocturna (HPN), en el que su diana farmacológica forma parte del sistema del complemento.
Natalia Campos-González, Susana Ruiz-Jiménez, Johanna Rodríguez-Jiménez, Luz Chacón-Jiménez   +3 more
doaj   +1 more source